CEFTOLOZANE AND BETA-LACTAMASE INHIBITOR

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire De Nimes, Assistance Publique Hopitaux De Paris

Conditions

Serious infections in critically ill patients treated with antibioticsantibiotic therapy in Sepsis

Phase 3

BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis

Not yet recruitingCTIS2024-516849-39-01

Assistance Publique Hopitaux De Parisantibiotic therapy in Sepsis

Target: 600Updated: 2025-12-02

Phase 4

Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol - A multi-national pharmacokinetic/pharmacodynamic cohort study to determine whether contemporary antibiotic dosing for critically ill patients achieves therapeutic exposures.

Not yet recruitingCTIS2024-516232-10-00

Centre Hospitalier Universitaire De NimesSerious infections in critically ill patients treated with antibiotics

Target: 200Updated: 2025-10-17